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Abstract
Objectives: Parents living with HIV who disclose their HIV status to their children could benefit from the parental HIV
disclosure. However, it is also very challenging because of persistent stigma and discrimination against HIV. This report describes
the study design and protocol of the “Interactive Communication with Openness, Passion, and Empowerment (iCOPE)”
randomized controlled trial aimed at assisting parents living with HIV in conducting culturally and developmentally appropriate
disclosure to their uninfected children in China through trainings among both parents living with HIV and healthcare providers.
Methods: A total of 791 parents living with HIV with children aged between 6 and 15 years and 357 healthcare providers
were randomized into either the intervention group or control group. Intervention package for parents consisted of five 2-h
sessions focusing on positive coping, disclosure decision making, developing a developmentally appropriate disclosure plan,
and accessing social support and post-disclosure counseling. The intervention for healthcare providers was made up of two
45-min sessions organized around two primary themes: knowledge of child cognitive development and effective parent–child
communication skills in the context of parental disclosure. The control group received nutritional education of either five
2-h sessions (parents) or two 45-min sessions (healthcare providers). The outcome assessments were conducted at baseline,
6, 12, 18, 24, 30, and 36 months.
Conclusion: The iCOPE study is among the first efforts to develop and evaluate a theory-based and multi-level intervention
to promote culturally and developmentally appropriate parental HIV disclosure in China. It has implications for healthcare
providers, social workers, and policy makers as it will provide efficacy data on how to enhance appropriate parental HIV
disclosure and will shed light on developing a clinical guideline regarding parental HIV disclosure in China and other low- and
middle-income countries.
Keywords
HIV/AIDS, disclosure, parents, China, randomized controlled trial, intervention
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Introduction
Because programs preventing prenatal HIV transmission are
reaching a greater number of pregnant women worldwide
and are successfully reducing vertical transmission, an everincreasing majority of children born to HIV-positive mothers
are uninfected. In addition, new medical innovations and
increasing availability of antiretroviral therapy (ART) have
improved the health and longevity of HIV-positive parents,
which means they are more likely to raise their children for
many years after the initial diagnosis.1 For parents living
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with HIV (PLH), disclosing their HIV infection to their
seronegative children (“parental HIV disclosure”) becomes
an increasingly important issue in terms of the well-being of
parents, children, and families.
The global literature suggests that developmentally
appropriate parental disclosure, particularly for young children, can have positive effects for both the parent and child,
while non-disclosure and unplanned disclosure can result in
negative outcomes.2–4 However, for multiple reasons including fear of stigma and the psychological burden such knowledge might place on their children, PLH struggle about
whether, when, what, and how to disclose their HIV infection to children.5,6 Many of them do not disclose primarily
because they lack the confidence and behavioral skills to do
it appropriately and effectively.7 To date, the issues surrounding parental HIV disclosure have been understudied,
particularly in low- and middle-income countries (LMICs)
including China, where the HIV epidemic has been steadily
expanding.
While the actual HIV seroprevalence in China remains
uncertain, the current official estimate of number of people
living with HIV exceeds 1.2 million with 850,000 reported
cases.8 Our preliminary data confirm the global literature
that disclosure of parental HIV status to children is a significant challenge for PLH.9,10 We also investigated the societal
beliefs that will directly and indirectly impact the process
and consequences of parental HIV disclosure to their
children.4,5 First, stigmatization and perceptions of “fate” in
relation to illness and death affects parental decision-making
in relation to disclosure of their serostatus to their children.4,5
Within the context of familial obligations and the centrality
of the family within the Chinese social structure, the dissolution of a family regardless of reason (e.g. death) is considered shameful for all family members including children.11–13
In addition, parental illness or death may signify “bad fate,”
something that is at odds with the “natural” order of life
and death.14
Second, sharing emotional events with children is discouraged. The family-orientated societal perspective discourages
the disclosure of distressful events in general and HIV
serostatus in particular.15,16 Few parents or children would
openly grieve or be willing to discuss bereavement-related
family issues (particularly issues associated with shame or
stigma). Compounding this perspective is the widely held
belief in China that children do not have emotional
problems.17 A child’s needs to be aware of parental illness or
to be part of the family support system are therefore more
likely to be ignored or misunderstood in Chinese culture.17
In addition, respect and compliance to authority (including healthcare providers) could facilitate disclosure.
Healthcare providers are generally considered authoritative
in China. Professional assistance or guidance from care providers could therefore have a significant positive effect on
the decision-making process of parental HIV disclosure.
However, laws and institutional policy relating to HIV
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disclosure/notification are inconsistent in China.18 After a
patient is diagnosed HIV positive, healthcare providers
often struggle to decide who should be informed first:
patient or family members. Some healthcare providers avoid
direct notification to patients due to concerns about their
ability to cope, need to protect other family members (e.g.
spouse), and need for family support to the patient. Such
practice may inhibit PLH from talking directly and truthfully with their children and may increase the likelihood of
unplanned disclosure by other family members or through
children’s own observations.
Given parental HIV disclosure is a big challenge for PLH
in China and parents often need professional support in
making a decision about disclosure and managing developmentally appropriate disclosure to their children, we developed the theory-based, multi-level intervention “Interactive
Communication with Openness, Passion, and Empowerment”
(iCOPE) based on our preliminary studies and adaptation
of existing disclosure-related interventions. The iCOPE
intervention design was guided by a conceptual framework
(see Figure 1) adapted based on Disclosure Process Model
(DPM)19 and was also consistent with the Piaget’s theory of
children’s development.20 A cluster randomized controlled
trial (RCT) project was conducted from 2012 to 2018 to evaluate the efficacy of the iCOPE intervention with two parallel
groups (intervention and control) among PLH (either fathers
or mothers) and healthcare providers. Main findings will be
reported in other manuscripts soon. This current study protocol covers main items recommended by the Standard Protocol
Items Recommendations for Intervention Trials (SPIRIT
2013) checklist (see supplemental materials).21

Methods
Study setting
The proposed intervention was conducted in Guangxi
Zhuang Autonomous Region (“Guangxi”) in southern China.
Guangxi is one of the regions in China that is experiencing
the fastest growth of the HIV epidemic. In 1996, the first
person was diagnosed with HIV in Guangxi; since then,
Guangxi has witnessed an alarming increase in HIV prevalence. A total of 124,282 HIV/AIDS cases had been reported
by December 2017, representing a 78.70% increase since
June 2011 (69,548 HIV/AIDS cases) and placing Guangxi
third among 31 Chinese provinces in terms of HIV seropositive cases.22
In Guangxi, while both local Centers for Disease Control
and Prevention (CDC) and local hospitals can conduct HIV
screening and counseling, there is one designated primary
public hospital (specifically its HIV clinic) in each urban district/rural township that is working under the direction of the
city/county CDC to conduct clinical management and semiannual follow-ups for all HIV patients in the district/township. In collaboration with the Guangxi CDC, we ranked all
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Figure 1. Conceptual framework: disclosure process model.
This conceptual framework was adapted from Chaudoir et al.19

14 cities and 75 rural counties in Guangxi in terms of number
of reported HIV/AIDS cases. We selected the top two cities
(urban centers) and top eight rural counties with the largest
number of reported HIV/AIDS cases to participate in the
proposed study. In a similar fashion, the Guangxi CDC
ranked urban districts in the two cities and townships in the
eight rural counties and identified urban districts and rural
townships with at least 200 HIV/AIDS cases. We randomly
selected 40 of them as our project sites.

Participation eligibility
The inclusion criteria for PLH included (1) being at least
18 years of age, (2) having a confirmed diagnosis of HIV or
AIDS, (3) living with at least one child with 6–15 years of
age, and (4) having not disclosed their HIV status to their
children. Both biological and non-biological parents (if they
were the legal and primary guardians for the child, for
example, an individual spending at least 50% of the time
with the child) were eligible to participate, although the
number of non-biological parents was very small. The
exclusion criteria for PLH included (1) having linguistic,
mental, or physical inability to respond to assessment questions or to participate in intervention; (2) being currently
incarcerated or institutionalized for drug use or commercial

sex; and (3) having a plan to permanently relocate outside
the province within a year.
The inclusion criteria for healthcare providers included
(1) being at least 18 years of age, (2) working at one of the
participating HIV clinics, and (3) having regular contact
with PLH. The exclusion criteria for healthcare providers
included having a plan to permanently relocate outside the
province within a year.

Recruitment and assignment of interventions
The time schedule of enrollment, interventions, and assessments for participants is demonstrated by a schematic diagram recommended by the SPIRIT 2013 (Figure 2). The
sample size of the participants (both PLH and healthcare
providers) at each time point is presented by the consort
flowcharts (Figure 3). The PLH were recruited from the 40
participating HIV clinics (about 20 per clinic). Medical staff
or case managers at HIV clinics referred potential participants to local team members who visited each clinic twice a
week during the recruitment period. If both father and mother
in a family were eligible, mother or physically healthier parent was invited to participate. Local team staff screened parents for eligibility and explained the study design including
the potential benefits and risks and confidentiality issues.
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Figure 2. Summary of schedule of enrollment, interventions, and assessments (following SPIRIT 2013).21
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Figure 3. Consort flowchart of iCOPE intervention trial: (a) for parents and (b) for healthcare providers.

The sample size of a follow-up survey may be larger than those in previous surveys because participants who completed baseline but missed a survey
were allowed for future follow-ups.

Local team staff emphasized that efforts would be taken to
prevent any inadvertent direct or indirect disclosure of their
serostatus to children or others during the research.
The healthcare providers were recruited from the 40 clinics where we recruited PLH. Each of these HIV clinics was
typically staffed with approximately 15 healthcare providers
including physicians, nurses, case managers, counselors, and
medical social workers. Local team members individually
approached all the healthcare providers in HIV clinics (except
those trained facilitators for parents intervention) as well as
healthcare providers in other departments of the hospital who
had regular contact with HIV patients; explained the study
design including the purpose, procedure, risk and benefit, and
confidentiality issues; and invited them to participate. All
healthcare providers who agreed to participate provided
written informed consent prior to baseline assessment.
Local program coordinators assigned the parents and
healthcare providers by HIV clinics to either intervention or
control condition (20 clinics each) using a stratified block
randomization procedure.23 The stratified block randomization (rather than the simple randomization) was used to

produce relatively comparable groups between conditions
with regard to key contextual characteristics. We first stratified all 40 clinics into 10 blocks (with 4 clinics in each block)
based on their similarities in (1) number of HIV-positive
patients served by the clinics and (2) geographic locations
(rural or urban). Then, we randomly assigned two clinics
within each block to intervention and two to control. The
PLH who consented for group sessions were organized into
two groups in each clinic (with no more than 10 parents per
group) for the delivery of intervention/control sessions.

Intervention protocol
Parent intervention. The parent intervention curriculum was
modeled after the “Teaching, Raising, and Communicating
with Kids (TRACK)” program24 and “Teens and Adults
Learning to Communicate (TALC)” program.25 The TRACK
program is composed of three sessions (children’s typical
development stages and decision-making of disclosure;
mother–child communication; and behavioral practice for
disclosure) and we modeled after all the three sessions.
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The TALC is a 24-session program which can be organized
into two modules for PLH alone and PLH and their adolescent children. We modified three of eight sessions (i.e.
coping with illness, coping with meaning of illness, and
planning for the future) in Module 1 (the module for PLH)
with a focus on coping with HIV and post-disclosure adjustment. We substantially modified and adapted the intervention content and format for each intervention module based
on our preliminary HIV disclosure studies to fit local cultural context.
The primary goal of the parent intervention was to prepare and assist PLH to make developmentally appropriate
disclosure (or an articulated plan for such a disclosure) based
on children’s age and psychosocial maturity, family dynamics, and clinical outcomes of parental HIV. The parent curriculum consisted of five interactive training sessions
(120 min each session for 10 h total) with three specific
focuses: understanding the stages of childhood cognitive
development in the context of parental illness (Session 1
“Child’s readiness for disclosure”); improving the parents’
cognitive and behavioral skills related to parental HIV disclosure (Session 2 “Benefits and risks of disclosure,” Session
3 “How to tell and what to tell,” and Session 4 “Disclosure is
an ongoing process”); and improving parental psychosocial
well-being in adapting to living with HIV/AIDS (Session 5
“Cope with my infection/illness”). The curriculum addressed
the issues of child and family strengths and community support across sessions.
Healthcare provider intervention. Tasker’s four-phase model
(FPM) of disclosure emphasizes the importance of professional support in each of the four phases of a planned disclosure process (secrecy phase, exploratory phase, readiness
phase, and disclosure phase).26 Although not all disclosures
automatically start at the secrecy stage, the model suggests a
critical role of healthcare providers and parent–provider relationship at different time points leading to disclosure. Guided
by Tasker’s FPM, the goal of healthcare provider intervention
was to train healthcare providers to assist PLH in creating an
appropriate disclosure plan that could meet the individual
needs of the children and families and provid PLH with continuous support during the disclosure process. The intervention curriculum consisted of two 45-min sessions organized
around two primary themes: (1) knowledge of child cognitive
development and (2) effective parent–child communication
skills in the context of parental disclosure (e.g. how to help
children understand HIV). These two sessions were developed by modifying (and shortening) similar components in
the parent curriculum. The first component also contained a
short clinical guide that was modeled after a single-page
“Step by Step Guide for Conversation with Children (Toward
Disclosure)” developed by an interdisciplinary team of
clinicians and researchers in South Africa (“SA Guide”).27
Although we were not aware of evaluation data regarding its
efficacy, the SA Guide was based on the principles of child
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cognitive development and was originally designed for use
by healthcare professionals and counselors working with
HIV-positive children and their caregivers. The SA Guide
analyzed the developmental level of the children and recommended level of disclosure (no disclosure, early disclosure,
partial disclosure, and full disclosure), content of disclosure,
and the aim of the disclosure for four age groups of children
(0–4 years, 5–7 years, 8–11 years, 12–14 years). We culturally
adapted the SA Guide in China and used it in training healthcare providers in China to help PLH to make appropriate disclosure to their uninfected children.
Control group protocol. The attention control condition for
parents was five 2-h sessions of nutrition education curriculum. The nutrition curriculum was modeled after the “Simply Good Eating” curriculum developed at University of
Minnesota.28 The Minnesota curriculum was modified in
accordance with current “Dietary Guidelines for Chinese
Residents.”29 The modified curriculum consisted of five 2-h
interactive training sessions with aims to increase parents’
knowledge of nutrition (Session 1: Food variety; Session 2:
Food for growing child), healthy diets and cooking practice
(Session 3: Fat, salt, and sugar; Session 4: Fruits, vegetables,
and minerals), and food safety (Session 5: Food safety). The
control curriculum for healthcare providers was a shortened
version (90 min) of the nutrition education curriculum with
two components: food for growing child and food safety.

Staff training
Intervention facilitators (two nurses or other paraprofessionals from each of the 40 intervention trial sites) were
trained and certified to deliver the parent sessions (with
separate training for intervention and control facilitators).
Training for parent intervention was a 4-day retreat including 3 days on content of the sessions and facilitator skills
and 1 day on research ethics. Eight (four pairs) health educators from Guangxi CDC were trained to deliver the care provider sessions through a 2-day training retreat (1 day for
intervention content and 1 day for research ethics). Survey
interviewers (two CDC staff in each study site) also received
2-day training (1 day for survey study and 1 day for research
ethics). In the training workshops, we used the drafts of
intervention manuals (for both PLH and healthcare provider
interventions) and survey protocol and then finalized the
manuals and protocol based on the feedback collected from
the training workshops. The intervention manuals were not
“word for word,” but covered all the guidelines, knowledge
points, instructions of intervention activities, and supplemental materials.

Intervention delivery
Parent sessions. The five 2-h parent intervention and control
sessions were delivered one session per week for 5 weeks in
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the clinics where the parents were recruited or nearby community space if the spaces in some of the clinics were inadequate for conducting the group sessions. The sessions were
delivered in either group sessions (for parents who felt comfortable doing so) or tailored for one-on-one sessions (for
parents who preferred this option). Two trained facilitators
delivered the materials through discussions, role-play, exercise, and/or games (for group sessions). The same two facilitators were assigned to deliver all the five sessions in each
clinic to increase group cohesion and/or rapport with parents. The day of each session was scheduled at least 1 week
in advance with periodic reminders to the parents, including
a reminder by the facilitator on the day before the scheduled session. Refreshments were served at each session.
Healthcare provider sessions. The 90-min healthcare provider
training (both intervention and control conditions) consisted
of two 45-min modules that were delivered individually or in
a small group (three to five healthcare providers) in the clinic
setting by trained facilitators (e.g. health educators from the
provincial CDC). Ideally, two modules were delivered on the
same day. However, given the variation of clinical schedules
among healthcare providers in a clinic, the delivery schedule
was flexible and individually tailored (e.g. two modules
could be given on two different days or over multiple short
sessions). Immediately following randomization, the intervention facilitators reviewed the situation of the clinics and
contextualized each session as necessary based on the healthcare providers’ workload and clinic schedule. Facilitators
also worked with each healthcare provider during the consent process to develop an individualized plan/schedule for
assessment, training, and follow-up.
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Outcome measures
Primary outcomes for parent measures included the number
of participants who have disclosed their HIV serostatus to
their children and participants’ stage status regarding parental disclosure. Other key outcomes included perceptions and
plans for parental disclosure, Derlega’s scales on reasons for
disclosure or non-disclosure,30 Delaney’s scale for child’s
reaction to the disclosure,31 depressive symptoms (Center for
Epidemiologic Studies Depression Scale (CES-D)),32,33
stress (Perceived Stress Scale),34 substance use (tobacco use,
alcohol use (alcohol use disorders identification test
(AUDIT)),35 and other drug use), sexual behavior and reproductive health, HIV-related quality of life (Medical Outcomes
Study HIV Health Survey (MOS-HIV)),36 medical adherence (treatment history, knowledge about ART and adherence, and adherence to care and medications), and HIV
clinical and immunologic status (most recent CD4 count,
viral load, and disease progression).
Primary outcomes for healthcare provider included experience in HIV notification and disclosure. Other key outcomes included knowledge of child cognitive development,
knowledge of effective parent–child communication skills,
perceived roles of healthcare providers in the disclosure process, and perceived self-efficacy and self-readiness of assisting their clients in parental disclosure.
Most of the demographic, psychosocial, and behavioral
measurements we used in the project were valid and reliable
measures with acceptable psychometric properties. The
questionnaires used in this study were also pilot tested among
20 parents and 10 healthcare providers to get participants’
perspectives on the clarity, cultural sensitivity, and developmental appropriateness of relevant measures.

Intervention fidelity

Data collection procedure

The following measures were used to assure fidelity to content and delivery of the intervention protocol: (1) institution of monitoring actual intervention implementation. The
assistant intervention facilitators completed the fidelity
process form for each session including content delivered,
time allocated, participation rate, and main activities covered by the sessions. The local team staff collected and
checked the fidelity process forms promptly. If any discrepancy between the protocol and the implementation emerged,
the intervention facilitators would be informed in a timely
manner and necessary steps would be taken to prevent
deviations from the intervention protocol; and (2) audiorecording all the sessions. After each session, the facilitators uploaded the recording to a designated USB flash
drive. The Chinese investigators randomly selected and
reviewed 20% of the sessions and completed the fidelity
process form for these sessions. These “independent” process measures were compared with the ones completed by
the facilitators and feedback concerning fidelity would be
provided to the facilitators promptly.

Parent survey. Interviewers (who were blinded to the intervention assignment) administered the baseline and six follow-up
surveys (every 6 months up to 36 months post-intervention)
to the parents. The parent surveys were administered in a
private room (e.g. doctor’s office) at district/township hospitals where these parents were recruited. Interviewers administered the questionnaire orally to a parent one-on-one. The
interviewer read each question in the questionnaire, and the
participant gave an oral response to the interviewer. By using
this method, we could ensure that varying degrees of literacy
did not affect the individual’s ability to understand the items.
Clarifications were provided by the interviewers as needed.
The survey usually took 60 min for parents. Participants
were offered a short break after 30 min of assessment or as
needed.
Healthcare provider survey. The participating healthcare providers were asked to complete baseline and six follow-up surveys (6-, 12-, 18-, 24-, 30-, and 36-months post-intervention)
in HIV clinics where they were recruited. The questionnaires
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were self-administered and interviewers were presented during the survey to provide necessary clarification. The survey
took about 15 min to complete.

Data management and data protection
A data manager/biostatistician at University of South
Carolina (UofSC) developed the data management procedures and data entry modules for all quantitative data and
trained the data manager at Guangxi CDC. All data were
double-entered into SPSS data station and backed up daily
by skilled research assistants (the SPSS file can be directly
read into SAS or covert to seven other different formats for
analysis if needed). All the hard copies of the assessment
instruments were kept in a secured space at the collaborators’
offices at Guangxi CDC. Participants’ confidentiality was
maintained through the use of arbitrary identification numbers (ID) on questionnaires and in databases. Upon completion of the survey, the completed questionnaire, which could
be linked to the participant only by a unique numerical ID,
was put in a sealed envelope and returned to the project
office at Guangxi CDC for data entry. A master list of IDs
and name of research participants was kept in a locked file
cabinet and password-protected file at principal investigator’s (PI) office at UofSC and at in-country PI’s office at
Guangxi CDC.

Sample size and power analysis
Because of the absence of empirical data on the effect of
parental disclosure intervention in China or any other
LMICs, we conservatively assumed a “smaller-thanmedium” effect of our proposed intervention on the primary parent outcomes (e.g. rate of parental disclosure or
plan to disclosure). According to the range of effect size
established by Cohen,37 Cohen’s d = 0.20 represents a
“small effect” and d = 0.50 represents a “medium effect.”
To be conservative in our power analysis, we assumed a
smaller-than-medium effect size (Cohen’s d = 0.35) for
the long-term effect (i.e. 36-month follow-up) of our proposed intervention. In addition, we assumed a two-tailed
test at alpha = 0.05.
The sample size of the participants by 36-month follow-up
was 690. However, the unit of randomization in this study
was not the individual parents, but rather the clinics; the sample size calculation, assuming that the unit of randomization
was the individual, needs to be adjusted for clustering effect,
for example, intraclass correlation (ICC). Donner et al.23
developed a procedure to determine an “effective sample size
(ESS)” in such situation: ESS = kn/[1 + (n – 1)ICC] (where k
is the number of clusters, n is the number of individuals in
each cluster, and kn is the actual sample size if the unit of
randomization is the individual). Because there was no clinic
level ICC data available in the literature, we conservatively
assumed a large ICC of 0.10 for clustering effect (for a total
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of 40 clinics and two groups of parents in each clinic with a
maximum of 10 parents per group). According to Donner’s
procedure,23 a sample size of 690 yields an ESS of 363 with
an ICC of 0.10.
According to the sample size estimation procedure developed by Cohen,37 when the sample size was 360 (or 180 participants in each intervention cell) and the effect size was 0.35
(Cohen’s d), the power of analysis would be 0.91. Thus, our
sample of 791 at baseline (or 690 at 36-month follow-up) provides adequate power to test the efficacy of this intervention.

Discussion
We hypothesize that the iCOPE intervention will demonstrate efficacy in helping PLH to make developmental appropriate disclosure to children or make a developmentally
appropriate plan of disclosure; as a result, the intervention
will demonstrate short-, medium-, and long-term efficacy in
improving well-being of parents, children, and families;
likewise, the intervention will increase provider awareness,
willingness, and confidence in their role in assisting PLH
with disclosure to children.
The proposed study has important innovations and potentials to advance scientific knowledge in several ways. First,
it will provide new cross-cultural evidence to support theorybased intervention. The proposed study addresses the dearth
of targeted interventions supporting parental efforts in disclosing their HIV status to their children in resource-poor
settings. Although there is a growing interest in parental HIV
disclosure among researchers and practitioners, the theoretical frameworks guiding the disclosure research and the
development of culturally and developmentally appropriate
interventions are limited. Although some theoretical/
conceptual models have been developed and tested for HIV
disclosure,38,39 they have not been explicitly applied to
parental disclosure to uninfected children. The innovative
use of the child development stage theory and DPM in this
research will enable us to address the developmental and
cognitive aspects of parental HIV disclosure and generate
novel insights and valuable data that will inform the development of evidence-based intervention strategies to facilitate
parental HIV disclosure among PLH in low-resource settings
worldwide.
Second, the proposed study suggests an innovative paradigm shift. Disclosure has been treated as a single event (disclosed vs non-disclosed) in many studies without taking into
consideration the child’s cognitive development stage.4 The
iCOPE intervention is centered on child developmental theory with a shift of conceptualization of parental disclosure
from a “discrete event” to a “gradient process” that is aligned
with a child’s cognitive development. This study will emphasize a child’s cognitive ability to understand information of
an emotion-laden nature during the process of disclosure as
well as the importance of such disclosure to their normal
development and maturation.

Li et al.
Last but not least, this study applies a novel intervention
approach. While available studies suggested high desire
from PLH to obtain professional guidance and support during the disclosure process due to complexity of parental HIV
disclosure to children,40 intervention studies related to parental HIV disclosure to children were limited worldwide with
no evidence-based intervention or clinical guideline existing
in low-resource settings.41 The proposed intervention takes a
system perspective to engage both parents and care providers, examines the potential role of gender in parental disclosure by including both mothers and fathers, and takes a
“task-shifting” approach by training a large number of nurses
or other paraprofessionals to deliver the parent intervention
so that the intervention can be implemented and sustained in
typical HIV care settings.
The iCOPE intervention is among the first efforts to
innovatively develop and test a multi-level theory-based
parent HIV disclosure to promote developmental appropriate disclosure to children or make a developmentally appropriate plan of disclosure, and to improve psychological
well-being and quality of life of parents, children, and families. The intervention also aims to increase provider awareness, willingness, and confidence in their role in assisting
PLH with disclosure to children. Once proven efficacious,
iCOPE could be potentially adapted and tailored to other
settings in China and LMICs where HIV disclosure remains
a big challenge for parents living with HIV. We will report
the intervention efficacy when we finish data analysis and
the impact evaluation.
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